Company attributes
Location
B2X
CEO
Founder
Pitchbook URL
Legal Name
G+FLAS Life Sciences Co., Ltd.
Subsidiary
Legal classification
Number of Employees (Ranges)
11 – 50
Full Address
Suite 1F, 38 Nakseongdae-ro, Gwanak-Gu, Seoul 08790, Korea
Investors
Founded Date
2014
Total Funding Amount (USD)
25,410,000
Latest Funding Round Date
August 2019
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
G+FLAS Life Sciences Co., Ltd. is a Korean-based CRISPR/Cas genome editing biotech company that develops genome editing application products, with a focus on immunotherapy treatments for cancer. It offers research and experimental development on medical sciences and pharmacy.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
